Published Date: 17 Feb 2023
Noise can play an important role in the initiation and progression of ischemic heart disease. Researchers from the Department of Cardiology at the University Medical Center Mainz have found that noise exposure...
Read Full NewsSanofi's tolebrutinib fails to meet key trial endpoints for multiple sclerosis, delaying FDA review and raising questions about its future in treatment.
Neal K. Shah talked about how social robots could support emotional well-being in patients with neurologic conditions by reducing loneliness and promoting engagement in health-related activities.
Christopher Kenney, MD, FAAN, chief medical officer at Xenon Pharmaceuticals, reviews encouraging long-term data behind azetukalner, a first-in-class Kv7 channel opener, as a potential treatment for focal onset seizures.
This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.
Chronic Pain Associated With Significantly Reduced Ability to Relax Muscles
Global Data Suggest Increased Prevalence of Focal Segmental Glomerulosclerosis
Older Patients on Maintenance Dialysis Underrepresented in RCTs
1.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
2.
healthy despite having advanced cancer.
3.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
4.
Scientists identify dual protein targets to weaken pancreatic cancer defenses
5.
Nasal therapeutic HPV vaccine could prevent cervical cancer
1.
Unlocking Life Expectancy After Subdural Hematoma: A New Hope
2.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
3.
The latest Hematocrit: An Overview of Red Blood Cell Health
4.
Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education
5.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation